[fcb5af]: / literature / by_gene / PTPN6.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35941532 10.1186/s10020-022-00518-0 2022 Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma. PTPN6
2 32035162 10.1016/j.phrs.2020.104682 2021 Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells. PTPN6
3 32449435 10.1080/15476286.2020.1772559 2021 Burkitt lymphoma-related <i>TCF3</i> mutations alter TCF3 alternative splicing by disrupting hnRNPH1 binding. PTPN6
4 32732362 10.3324/haematol.2020.254276 2021 Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1. PTPN6
5 33290262 10.18632/aging.202146 2021 The improved anticancer effects of Bortezomib-loaded hollow mesoporous silica nanospheres on lymphoma development. PTPN6
6 33373915 10.1016/j.biopha.2020.111166 2021 Yishen-tongbi decoction inhibits excessive activation of B cells by activating the FcγRIIb/Lyn/SHP-1 pathway and attenuates the inflammatory response in CIA rats. PTPN6
7 33562835 10.3390/molecules26040848 2021 Polyphyllin D Shows Anticancer Effect through a Selective Inhibition of Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP2). PTPN6
8 30470842 10.1038/s41417-018-0057-7 2020 Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma. PTPN6
9 32049043 10.1016/j.ccell.2020.01.006 2020 Unraveling the Signaling Balance of Activation and Exhaustion of CAR T Cells. PTPN6
10 30420593 10.1038/s41408-018-0138-8 2019 Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma. PTPN6
11 29793312 10.1016/j.biopha.2017.11.033 2018 Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia. PTPN6
12 29794468 10.1159/000490019 2018 Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma. PTPN6
13 29794791 10.1097/MD.0000000000010871 2018 Oncogenomic analysis identifies novel biomarkers for tumor stage mycosis fungoides. PTPN6
14 29925063 10.1159/000490106 2018 Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment? PTPN6
15 26373709 10.3109/10428194.2015.1090573 2017 Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia. PTPN6
16 27959415 10.3892/or.2016.5308 2017 Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma. PTPN6
17 28031181 10.1182/blood-2016-06-722900 2017 Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK. PTPN6
18 28210822 10.1007/s10147-017-1100-7 2017 Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma. PTPN6
19 25614448 10.1158/1078-0432.CCR-14-1216 2016 Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. PTPN6
20 25951043 10.1080/15548627.2015.1017192 2016 The role of STAT3 in autophagy. PTPN6
21 26498513 10.3892/or.2015.4347 2016 Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL. PTPN6
22 26565811 10.18632/oncotarget.6300 2016 Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma. PTPN6
23 24952874 10.18632/oncotarget.2054 2015 RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells. PTPN6
24 25117354 10.4238/2014.August.7.11 2015 Effect of Jianpi Bushen prescription on the expression of SHP-1 and apoptosis-related genes in chemically damaged model mice. PTPN6
25 25799995 10.1038/nature14231 2015 Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. PTPN6
26 26246572 10.1128/JVI.01525-15 2015 Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival. PTPN6
27 23979523 10.1038/leu.2013.251 2014 Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy. PTPN6
28 24492847 10.1101/cshperspect.a014282 2014 Oncogenic mechanisms in Burkitt lymphoma. PTPN6
29 22488585 10.1002/hon.2010 2013 Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma. PTPN6
30 22791880 10.1158/1078-0432.CCR-12-0101 2013 Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma. PTPN6
31 22962271 10.1158/0008-5472.CAN-12-0939 2013 Genetic screening for synthetic lethal partners of polynucleotide kinase/phosphatase: potential for targeting SHP-1-depleted cancers. PTPN6
32 21818116 10.1038/leu.2011.198 2012 Constitutive activation of STAT3 in Sézary syndrome is independent of SHP-1. PTPN6
33 21949826 10.1371/journal.pone.0024995 2012 Short Stat5-interacting peptide derived from phospholipase C-β3 inhibits hematopoietic cell proliferation and myeloid differentiation. PTPN6
34 19619438 2011 [Effect of As2O3 on demethylation of SHP-1 gene in human lymphoma cell line T2]. PTPN6
35 21436254 10.1210/me.2010-0486 2011 B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR. PTPN6
36 21592569 10.1016/j.leukres.2011.04.015 2011 Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia. PTPN6
37 19950550 2010 [As2O3 induces demethylation and up-regulates transcription of SHP-1 gene in human lymphoma cell line T2 cells]. PTPN6
38 19965664 10.1182/blood-2009-08-237537 2010 Rituximab inhibits B-cell receptor signaling. PTPN6
39 20424160 10.1074/jbc.M110.121988 2010 The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions. PTPN6
40 19052984 10.1080/10428190802455859 2009 Protein-tyrosine phosphatase activity maintains the viability of hairy cells and modulates their response to interferon-alpha. PTPN6
41 19206008 10.1080/08880010802625530 2009 Expression of PTEN and SHP1, investigated from tissue microarrays in pediatric acute lymphoblastic, leukemia. PTPN6
42 19454653 10.1189/jlb.0109037 2009 Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner. PTPN6
43 19647218 10.1016/j.ccr.2009.07.005 2009 The SPS affair: a complex tale of illicit proliferation. PTPN6
44 19647226 10.1016/j.ccr.2009.05.018 2009 Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. PTPN6
45 18502033 10.1016/j.canlet.2008.04.020 2008 TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation. PTPN6
46 16181557 2007 [Nasal natural killer/T-cell lymphoma genes]. PTPN6
47 16389548 10.1007/s00109-005-0020-6 2007 SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. PTPN6
48 17239936 10.1016/j.humpath.2006.09.012 2007 Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphoma. PTPN6
49 16469875 10.1182/blood-2005-06-2421 2006 SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling. PTPN6
50 16825495 10.1182/blood-2006-04-017434 2006 Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. PTPN6
51 16871283 10.1038/sj.leu.2404323 2006 Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma. PTPN6
52 15363033 10.1111/j.1440-1827.2004.01677.x 2005 SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts. PTPN6
53 15580314 10.1038/sj.onc.1208032 2005 Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. PTPN6
54 15870198 10.1073/pnas.0501959102 2005 STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. PTPN6
55 14551136 10.1182/blood-2003-07-2617 2004 A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. PTPN6
56 14614518 10.1038/sj.leu.2403216 2004 SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. PTPN6
57 14624462 10.1002/jcb.10727 2004 SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases. PTPN6
58 14630083 10.1016/s0145-2126(03)00158-9 2004 Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells. PTPN6
59 14691303 10.1097/01.lab.0000106503.65258.2b 2004 Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation. PTPN6
60 15317731 10.1182/blood-2004-03-1151 2004 Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma. PTPN6
61 12591278 10.1016/s0301-472x(02)01025-1 2003 Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells. Implications for lymphomagenesis. PTPN6
62 12657462 10.1016/s0378-1119(03)00400-1 2003 The function of the protein tyrosine phosphatase SHP-1 in cancer. PTPN6
63 11698646 10.1073/pnas.231486598 2002 PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. PTPN6
64 11832424 10.1152/ajprenal.00184.2001 2002 Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2 -/- mice. PTPN6
65 12130517 10.1182/blood-2001-12-0303 2002 Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling. PTPN6
66 12145687 10.1038/sj.leu.2402546 2002 SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signaling. PTPN6
67 12438221 2002 Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. PTPN6
68 11157475 10.1182/blood.v97.3.608 2001 SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. PTPN6
69 11340297 10.1159/000049187 2001 Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a. PTPN6
70 11420468 10.1097/00000478-200107000-00015 2001 SHP-1 expression by malignant small B-cell lymphomas reflects the maturation stage of their normal B-cell counterparts. PTPN6
71 11513543 10.1006/clim.2001.5082 2001 Analysis of the Ser786Pro interleukin-4 receptor alpha allelic variant in allergic and nonallergic asthma and its functional consequences. PTPN6
72 10609786 10.1080/10428199909169613 2000 Gene expression of the hematopoietic cell phosphatase in juvenile myelomonocytic leukemia. PTPN6
73 10617656 10.1074/jbc.275.1.599 2000 Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. PTPN6
74 10623804 10.4049/jimmunol.164.2.631 2000 Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions. PTPN6
75 10747947 10.1074/jbc.M000689200 2000 Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. PTPN6
76 10914554 10.1038/sj.leu.2401822 2000 The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor. PTPN6
77 11021818 10.1016/S0002-9440(10)64629-9 2000 Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter. PTPN6
78 10072516 1999 Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. PTPN6
79 10222053 10.1006/cimm.1999.1475 1999 Bovine leukemia virus transmembrane protein gp30 physically associates with the down-regulatory phosphatase SHP-1. PTPN6
80 10228003 1999 CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1. PTPN6
81 10229324 10.1016/s0145-2126(98)00173-8 1999 Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia. PTPN6
82 10382761 10.1002/(SICI)1521-4141(199906)29:06&lt;1980::AID-IMMU1980&gt;3.0.CO;2-B 1999 Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase. PTPN6
83 10396068 10.1007/978-3-642-60162-0_36 1999 Involvement of the SHP-1 tyrosine phosphatase in regulating B lymphocyte antigen receptor signaling, proliferation and transformation. PTPN6
84 10397152 10.1016/s0165-2478(99)00026-7 1999 Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation. PTPN6
85 10457220 10.1046/j.1365-2567.1999.00825.x 1999 H-2Dd engagement of Ly49A leads directly to Ly49A phosphorylation and recruitment of SHP1. PTPN6
86 9500795 10.1084/jem.187.6.929 1998 Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cells. PTPN6
87 9670943 1998 B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation. PTPN6
88 9743328 1998 Superclustering of B cell receptor and Fc gamma RIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1. PTPN6
89 9348315 10.1084/jem.186.9.1575 1997 Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes. PTPN6
90 9368621 10.1002/eji.1830271025 1997 Co-localization of Fyn with CD3 complex, CD45 or CD28 depends on different mechanisms. PTPN6
91 8632004 10.1074/jbc.271.7.3856 1996 The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. PTPN6
92 7539038 10.1084/jem.181.6.2077 1995 Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. PTPN6
93 7657601 10.1074/jbc.270.35.20305 1995 Hematopoietic cell phosphatase is recruited to CD22 following B cell antigen receptor ligation. PTPN6
94 8114715 10.1128/mcb.14.3.1824-1834.1994 1994 Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. PTPN6